Zobrazeno 1 - 10
of 964
pro vyhledávání: '"Didier Samuel"'
Autor:
Ting ting Cai, Christophe Desterke, Juan Peng, Jean Agnetti, Peixuan Song, Dalila Ouazib, Alexandre Dos Santos, Catherine Guettier, Didier Samuel, Ama Gassama‐Diagne
Publikováno v:
Molecular Oncology, Vol 18, Iss 10, Pp 2369-2392 (2024)
Intrahepatic cholangiocarcinoma (iCCA) is a highly heterogeneous and aggressive liver cancer with limited therapeutic options. Precise classification and immunotherapy are perspectives to improve the treatments. We reported the role of septin 9 in ap
Externí odkaz:
https://doaj.org/article/0d7ea371336a4bdea92b034e03517704
Autor:
Sophie-Caroline- Sacleux, Philippe Ichaï, Audrey Coilly, Marc Boudon, Elise Lemaitre, Rodolphe Sobesky, Eleonora De Martin, Valérie Cailliez, Ilias Kounis, Edoardo Poli, Marie-Amélie Ordan, Alina Pascale, Jean-Charles Duclos-Vallée, Cyrille Feray, Daniel Azoulay, Eric Vibert, Daniel Cherqui, René Adam, Didier Samuel, Faouzi Saliba
Publikováno v:
JHEP Reports, Vol 6, Iss 1, Pp 100929- (2024)
Background & Aims: Retrospective studies have reported good results with liver transplantation (LTx) for acute-on-chronic liver failure (ACLF) in selected patients. The aim of this study was to evaluate the selection process for LTx in patients with
Externí odkaz:
https://doaj.org/article/541634f6b0cb4d77bb7cff1ae1bafa06
Autor:
Alexandre Joosten, Brigitte Ickx, Zakaria Mokhtari, Luc Van Obbergh, Valerio Lucidi, Vincent Collange, Salima Naili, Philippe Ichai, Didier Samuel, Antonio Sa Cunha, Brenton Alexander, Matthieu Legrand, Fabio Silvio Taccone, Anatole Harrois, Jacques Duranteau, Jean-Louis Vincent, Joseph Rinehart, Philippe Van der Linden
Publikováno v:
BMC Anesthesiology, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/6046220be11049ba89a9bb9f8642f385
Autor:
Christophe Desterke, Chuhan Chung, David Pan, Michael Trauner, Didier Samuel, Daniel Azoulay, Cyrille Feray
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 1, Pp 49-62 (2023)
Background and Aims: Primary sclerosing cholangitis (PSC) is a probable autoimmune liver disease characterized by persistent and progressive biliary inflammation that leads to biliary infection, cirrhosis, or cholangiocarcinoma. Genome-wide omics dat
Externí odkaz:
https://doaj.org/article/02a6cf5248d44bad823096f857d9de56
Autor:
Alexandre Joosten, François Martin Carrier, Aïmane Menioui, Philippe Van der Linden, Brenton Alexander, Audrey Coilly, Nicolas Golse, Marc-Antoine Allard, Valerio Lucidi, Daniel Azoulay, Salima Naili, Leila Toubal, Maya Moussa, Lydia Karam, Hung Pham, Edita Laukaityte, Youcef Amara, Marc Lanteri-Minet, Didier Samuel, Olivier Sitbon, Marc Humbert, Laurent Savale, Jacques Duranteau
Publikováno v:
BMC Anesthesiology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background In patients with end stage liver disease (ESLD) scheduled for liver transplantation (LT), an intraoperative incidental finding of elevated mean pulmonary arterial pressure (mPAP) may be observed. Its association with patient outco
Externí odkaz:
https://doaj.org/article/d4e6180a0cce443e859d2bd7021cdf30
Autor:
François Villeret, Fanny Lebossé, Sylvie Radenne, Didier Samuel, Bruno Roche, Jean-Yves Mabrut, Vincent Leroy, Georges-Philippe Pageaux, Rodolphe Anty, Sylvie Thevenon, Sinafa Si Ahmed, Aaron Hamilton, Marintha Heil, Caroline Scholtès, Massimo Levrero, Barbara Testoni, Fabien Zoulim, Françoise Berby, Isabelle Bordes, Daniel Cherqui, Tarek Debs, Christian Ducerf, Jean-Charles Duclos-Valle, Marie-Noëlle Hilleret, Antonio Iannelli, Kayvan Mohkam, Francis Navarro
Publikováno v:
JHEP Reports, Vol 5, Iss 6, Pp 100728- (2023)
Background & Aims: Prophylaxis with nucleos(t)ide analogues (NUCs) and hepatitis B immunoglobulin (HBIG) has decreased the rate of HBV recurrence after orthotopic liver transplantation (OLT), but the duration of this prophylaxis remains debated. Our
Externí odkaz:
https://doaj.org/article/d2cdbc7e25c84444b623acb9ace8575b
Autor:
Jean Agnetti, Vanessa Bou Malham, Christophe Desterke, Nassima Benzoubir, Juan Peng, Sophie Jacques, Souad Rahmouni, Emanuel Di Valentin, Tuan Zea Tan, Didier Samuel, Jean Paul Thiery, Ama Gassama-Diagne
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-15 (2022)
Overexpression of isoform δ of phosphoinositide 3-kinase (PI3Kδ) promotes stemness in hepatocellular carcinoma cell lines and mouse liver, whereas its inhibition promotes EMT, suggesting a key role for PI3Kδ in epithelial plasticity.
Externí odkaz:
https://doaj.org/article/b4d2124ccf174f3b8ca36dab0e6b9aba
Autor:
François Villeret, Sébastien Dharancy, Domitille Erard, Armand Abergel, Louise Barbier, Camille Besch, Olivier Boillot, Karim Boudjema, Audrey Coilly, Filomena Conti, Christophe Corpechot, Christophe Duvoux, François Faitot, Stéphanie Faure, Claire Francoz, Emiliano Giostra, Jean Gugenheim, Jean Hardwigsen, Marie-Noëlle Hilleret, Jean-Baptiste Hiriart, Pauline Houssel-Debry, Nassim Kamar, Guillaume Lassailly, Marianne Latournerie, Georges-Philippe Pageaux, Didier Samuel, Claire Vanlemmens, Faouzi Saliba, Jérôme Dumortier
Publikováno v:
JHEP Reports, Vol 5, Iss 3, Pp 100668- (2023)
Background & Aims: Liver transplantation (LT) is the only available treatment for end-stage non-alcoholic fatty liver disease (NAFLD) (related decompensated cirrhosis and/or hepatocellular carcinoma). The aim of our study was to evaluate the risk of
Externí odkaz:
https://doaj.org/article/6ba3741c70a94302adffa3db162da35b
Autor:
Steven Flamm, Eric Lawitz, Brian Borg, Michael Charlton, Charles Landis, K. Rajender Reddy, Mitchell Shiffman, Angel Alsina, Charissa Chang, Natarajan Ravendhran, Candido Hernandez, Christophe Hézode, Stacey Scherbakovsky, Renee-Claude Mercier, Didier Samuel
Publikováno v:
Viruses, Vol 15, Iss 10, p 2026 (2023)
A fixed-dose combination of sofosbuvir/velpatasvir (SOF/VEL) plus weight-based ribavirin (RBV) for 12 weeks is recommended for the treatment of patients with hepatitis C virus (HCV)-associated decompensated cirrhosis. However, large global studies, w
Externí odkaz:
https://doaj.org/article/620ad64d8bc644198848a98512cd84c1
Autor:
Georges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, Didier Samuel, Céline Dorival, Fabien Zoulim, Carole Cagnot, Thomas Decaens, Dominique Thabut, Tarik Asselah, Philippe Mathurin, François Habersetzer, Jean-Pierre Bronowicki, Dominique Guyader, Isabelle Rosa, Vincent Leroy, Olivier Chazouilleres, Victor de Ledinghen, Marc Bourliere, Xavier Causse, Paul Cales, Sophie Metivier, Véronique Loustaud-Ratti, Ghassan Riachi, Laurent Alric, Moana Gelu-Simeon, Anne Minello, Jérôme Gournay, Claire Geist, Albert Tran, Armand Abergel, Isabelle Portal, Louis d’Alteroche, François Raffi, Hélène Fontaine, Fabrice Carrat, Stanislas Pol, For the French ANRS CO22 Hepather Cohort
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background In HCV-infected patients with advanced liver disease, the direct antiviral agents-associated clinical benefits remain debated. We compared the clinical outcome of patients with a previous history of decompensated cirrhosis followi
Externí odkaz:
https://doaj.org/article/48e964b5c9d840cc88bf051e9f905689